Evidence map›Paper›PMID 29594219›Full record

ArticleClinical and translational radiation oncology2017

Feasibility of stereotactic body radiotherapy for locally-advanced non-small cell lung cancer.

Katrina Woodford, Vanessa Panettieri, Trieumy Tran Le, Sashendra Senthi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and translational radiation oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Contrast enhanced oesophageal avoidance for stereotactic body radiotherapy: Barium vs. Gastrografin.Technical innovations & patient support in radiation oncology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Katrina WoodfordAlfred Health Radiation Oncology, The Alfred, Melbourne, Victoria, Australia.
Vanessa PanettieriAlfred Health Radiation Oncology, The Alfred, Melbourne, Victoria, Australia.
Trieumy Tran LeAlfred Health Radiation Oncology, The Alfred, Melbourne, Victoria, Australia.
Sashendra SenthiAlfred Health Radiation Oncology, The Alfred, Melbourne, Victoria, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SBRT was feasible for approximately half of the locally-advanced NSCLC patients we assessed and for these patients has the potential to reduce a 30 fraction course to 12 fractions. Using SBRT in this setting requires compromises in techniques and further compromises may allow SBRT in a greater proportion of patients.

Indexed as

ElderlyHypofractionationLocally-advancedLung cancerStereotactic ablative radiotherapyStereotactic body radiotherapy

Identifiers

PMID29594219
PMCPMC5862638

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.